Back Bay in the Boston Globe: Challenge for Cancer Drug Startups Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsJanuary 27, 2017Drug Development, Oncology, Boston Life Science Ecosystem, Emerging Biotech
Back Bay in Wall Street Journal Newsletter: Biotech M&A Deals Expected to Increase Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsJanuary 17, 2017M&A, Investment Banking, Life Science IPOs
Back Bay in US News and World Report: Biggest Financial Headlines of 2016 Jonathan Gertler Posts, News, Back Bay in the NewsBack Bay Life Science AdvisorsJanuary 3, 2017Investment Banking, Biotech Financing
100 Years Later, Legacy of Patient Care Carries Us Forward Blog, Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsOctober 19, 2016
US News & World Report - Biotech Stocks Jonathan Gertler Posts, NewsJonathan Gertler, MDOctober 17, 2016
Pfizer To Acquire Medivation: From $1.00 TO $81.50 Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsSeptember 20, 2016M&A
Mass Bio: Industry & Academia, Begin with the End in Mind Blog, Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsAugust 1, 2016Academic-Industry Partnering, Tech Transfer
